aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Navitor Pharmaceuticals is a biopharmaceutical company focused on developing novel medicines by targeting the primary cellular nutrient signaling pathway. Their mission is to innovate treatments that address significant unmet medical needs, with a market focus on diseases influenced by cellular nutrient signaling.
Navitor has made significant strides in the biopharmaceutical industry, leveraging cutting-edge research to create impactful therapies. Their work has attracted attention from notable investors and industry leaders, underscoring their potential to transform medical treatment paradigms.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private
Main Product(s)
Pharmaceuticals
Technology
Biotech
Model Types
Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was Navitor Pharmaceuticals founded?
Navitor Pharmaceuticals was founded in 2010.
Where is Navitor Pharmaceuticals's headquarters located?
Navitor Pharmaceuticals's headquarters is located in Cambridge, CAM, GB.
When was Navitor Pharmaceuticals's last funding round?
Navitor Pharmaceuticals's most recent funding round was for $20.2M (USD) in April 2020.
How many employees does Navitor Pharmaceuticals have?
Navitor Pharmaceuticals has 36 employees as of Feb 5, 2024.
How much has Navitor Pharmaceuticals raised to-date?
As of July 05, 2023, Navitor Pharmaceuticals has raised a total of $98.2M (USD) since Apr 21, 2020.
Add Comparison
Total Raised to Date
$98.2M
USD
Last Update Apr 21, 2020
Last Deal Details
$20.2M
USD
Apr 21, 2020
Series Unknown
Total Employees Over Time
36
As of Feb 2024
Navitor Pharmaceuticals Address
Cambridge,
Cambridgeshire
United Kingdom
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts